FTC sues major pharmacy benefit managers more than insulin costs The agency introduced action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of life-preserving insulin prescription drugs. Never skip tomorrow's healthcare business news Let Healthcare Dive's absolutely free newsletter https://buschlightpeachcalories16160.blogolize.com/everything-about-healthcare-news-69913915